Positive Feline Clinical Trial Outcome Motivates Sorrento Therapeutics to Accelerate Human IND Filing of Resiniferatoxin (RTX) for Prolonged Non-Opioid Control of Post-Amputation Neuropathic Pain

Matt Turner
Patient Affordability

Amy Giles
Increasing Engagement

David Linetsky
Point-of-Care Marketing

Matthew Durham
Omnidynamic Marketing

Suma Ramadas, PhD
Medical Affairs

Liz Kane
Impactful Strategy

Paul Theisen
Patient Acquisition

Bud Bilanich
Success Coach

Brenda Snow
Authentic Patient Voice

Frank Burrell
Scientific Storytelling

Joey Cohen
Medication Adherence

Pat Purcell
Meeting Engagement

Daniel Sontupe
Market Access

Stacey Gandler
Brand Nourishment